PALO ALTO, Calif.--(BUSINESS WIRE)--Science Exchange, the leading marketplace for outsourced R&D™, announces a collaboration with LI-COR Biosciences to offer a suite of molecular imaging services based on LI-COR’s pioneer work in near-infrared fluorescence as a detection method.
Based in Lincoln, Nebraska, LI-COR Biosciences is a world leader in innovative imaging systems for proteomics and pre-clinical research. With more than 25 years of experience in providing molecular imaging technologies worldwide, the company now offers a broad range of custom research services for scientists. From development through screening, LI-COR is positioned to lend wide-ranging R&D assistance to scientists with a special emphasis on western blot reproducibility.
"Working with Science Exchange allows us to reach key researchers focusing on pre-clinical and clinical translation applications," says Greg Biggs, CEO of LI-COR. "Building on our established expertise in Western blot assays, protocol, and probe development and optimization, we can now offer our unique expertise in expanded areas of focus for custom services including validation, manufacturing, and analytical chemistry."
"Teaming up with LI-COR provides researchers with access to unique, in some cases, one of a kind services and products," said Elizabeth Iorns, Ph.D., co-founder and CEO of Science Exchange. "LI-COR has a clear leadership role in advancing imaging technology especially in the use of near-infrared detection."
About Science Exchange
Science Exchange is the world's leading marketplace for outsourced R&D™, providing large R&D organizations with the fastest path from discovery through development and commercialization. Science Exchange includes an efficient source-to-secure platform for ordering 6,000+ services from a network of more than 2,500 qualified outsourced research providers, all with pre-established contracts in place that protect client intellectual property and confidentiality. The platform increases access to innovation and improves productivity, freeing scientists from administrative tasks and delays associated with sourcing, establishing and managing service provider contracts. Additionally, the Science Exchange enterprise program enables large R&D organizations to consolidate research outsourcing spend into a single strategic relationship, driving efficiency, improving transparency and oversight, and delivering cost savings. Since being founded in 2011, Science Exchange has raised more than $58 million from Norwest Venture Partners, Maverick Capital Ventures, Union Square Ventures, Collaborative Fund, Index Ventures, OATV, the YC Continuity Fund, and others. For more information, visit www.ScienceExchange.com. Follow the company on Twitter @ScienceExchange.
About LI-COR Biosciences
LI-COR Biosciences is a pioneer in the development of near-infrared fluorescence labeling and detection systems for such areas as drug discovery, genomics, and small animal in vivo imaging. LI-COR provides the complete solution for quantitative Western blots with its Odyssey® Infrared Imaging Systems, C-DiGit® Chemiluminescent Blot Scanner, Image Studio™ analysis software, unique IRDye® secondary antibodies, and reagents. For small animal imaging the company offers BrightSite™ near-infrared fluorescent probes or bioluminescence on the Pearl® Trilogy imaging system. LI-COR IRDye near-infrared dyes are being used in human clinical trials for potential therapeutic and diagnostic applications including cancer treatments and surgical visualization. For more information, visit www.licor.com/bio.